Ibraheem Mahmood

Ibraheem Mahmood is a prominent figure in the field of healthcare and pharmaceuticals with a diverse and extensive background.

He studied Medicine at the prestigious University of Oxford, showcasing his strong educational foundation in the medical field.

Ibraheem Mahmood currently serves as the Chief Executive Officer and Co-founder of AMO Pharma LTD, demonstrating his leadership and entrepreneurial skills.

Prior to his role at AMO Pharma LTD, he was actively involved in various organizations and held key positions, including Co-founder and investor at Induction Healthcare Group PLC, Entrepreneur In Residence at Oxford Sciences Innovation, and Senior Vice President, Global Head, Clinical Technology Business at IQVIA.

His career has been marked by successful ventures and leadership roles, having also served as Chairman and Co-founder of AMO Pharma LTD, President and CEO of DrugDev, and in roles at Shire Pharmaceuticals, Investec, Aga Khan Health Service Pakistan, Nomura, and Accenture.

With his diverse experience across healthcare, pharmaceuticals, technology, and investments, Ibraheem Mahmood is a versatile professional who has made significant contributions to the industry.